Paul B. Myrdal - Publications

Affiliations: 
Pharmaceutical Sciences University of Arizona, Tucson, AZ 
Area:
Pharmaceutical Chemistry

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Younis US, Fazel M, Myrdal PB. Characterization of Tetracycline Hydrochloride Compounded in a Miracle Mouthwash Formulation. Aaps Pharmscitech. 20: 178. PMID 31041553 DOI: 10.1208/S12249-019-1388-X  0.351
2019 Vallorz E, Sheth P, Myrdal P. Pressurized Metered Dose Inhaler Technology: Manufacturing. Aaps Pharmscitech. 20: 177. PMID 31037395 DOI: 10.1208/S12249-019-1389-9  0.6
2019 Younis US, Vallorz E, Addison KJ, Ledford JG, Myrdal PB. Preformulation and Evaluation of Tofacitinib as a Therapeutic Treatment for Asthma. Aaps Pharmscitech. 20: 167. PMID 30993508 DOI: 10.1208/S12249-019-1377-0  0.37
2017 Sheth P, Grimes MR, Stein SW, Myrdal PB. Impact of Droplet Evaporation Rate on Resulting In Vitro Performance Parameters of Pressurized Metered Dose Inhalers. International Journal of Pharmaceutics. PMID 28599855 DOI: 10.1016/J.Ijpharm.2017.06.014  0.676
2016 Johnson JL, Guthrie D, Hyde J, Hanson T, Karlage K, Myrdal PB. The effect of a holding chamber on albuterol metered-dose inhaler product differences. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 117: 246-50. PMID 27613457 DOI: 10.1016/J.Anai.2016.07.016  0.349
2016 Franklin SJ, Younis US, Myrdal PB. Estimating the Aqueous Solubility of Pharmaceutical Hydrates. Journal of Pharmaceutical Sciences. 105: 1914-9. PMID 27238488 DOI: 10.1016/J.Xphs.2016.03.040  0.327
2016 Aodah A, Pavlik A, Karlage K, Myrdal PB. Preformulation Studies on Piperlongumine. Plos One. 11: e0151707. PMID 26982320 DOI: 10.1371/Journal.Pone.0151707  0.36
2015 Stein SW, Sheth P, Younis US, Mogalian E, Myrdal PB. Modeling and Understanding Combination pMDI Formulations with Both Dissolved and Suspended Drugs. Molecular Pharmaceutics. PMID 26258647 DOI: 10.1021/Acs.Molpharmaceut.5B00467  0.789
2015 Franklin SJ, Myrdal PB. Solid-State and Solution Characterization of Myricetin. Aaps Pharmscitech. 16: 1400-8. PMID 25986594 DOI: 10.1208/S12249-015-0329-6  0.377
2015 Sheth P, Stein SW, Myrdal PB. Factors influencing aerodynamic particle size distribution of suspension pressurized metered dose inhalers. Aaps Pharmscitech. 16: 192-201. PMID 25273026 DOI: 10.1208/S12249-014-0210-Z  0.672
2014 Sheth P, Bertsch MD, Knapp CL, Myrdal PB. In vitro evaluation of nonconventional accessory devices for pressurized metered-dose inhalers. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 113: 55-62. PMID 24814758 DOI: 10.1016/J.Anai.2014.04.006  0.578
2014 Myrdal PB, Sheth P, Stein SW. Advances in metered dose inhaler technology: formulation development. Aaps Pharmscitech. 15: 434-55. PMID 24452499 DOI: 10.1208/S12249-013-0063-X  0.665
2014 Stein SW, Sheth P, Hodson PD, Myrdal PB. Advances in metered dose inhaler technology: hardware development. Aaps Pharmscitech. 15: 326-38. PMID 24357110 DOI: 10.1208/S12249-013-0062-Y  0.627
2014 Franklin SJ, Dickinson SE, Karlage KL, Bowden GT, Myrdal PB. Stability of sulforaphane for topical formulation. Drug Development and Industrial Pharmacy. 40: 494-502. PMID 23611476 DOI: 10.3109/03639045.2013.768634  0.304
2013 Sheth P, Stein SW, Myrdal PB. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers International Journal of Pharmaceutics. 455: 57-65. PMID 23911912 DOI: 10.1016/J.Ijpharm.2013.07.061  0.684
2012 Karlage KL, Franklin SJ, Mufich WC, Goetz KJ, Sabelka JV, Hoye WL, Myrdal PB. Comparative evaluation of pharmaceutical products obtained in Mexico: augmenting existing scientific data. Drug Development and Industrial Pharmacy. 38: 808-14. PMID 22091930 DOI: 10.3109/03639045.2011.628678  0.737
2012 Stein SW, Sheth P, Myrdal PB. A model for predicting size distributions delivered from pMDIs with suspended drug International Journal of Pharmaceutics. 422: 101-115. PMID 22044537 DOI: 10.1016/J.Ijpharm.2011.10.035  0.648
2010 Guo D, Myrdal PB, Karlage KL, O'Connell SP, Wissinger TJ, Tabibi SE, Yalkowsky SH. Stability of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in combination. Aaps Pharmscitech. 11: 247-52. PMID 20151336 DOI: 10.1208/S12249-010-9383-2  0.351
2010 Stratton SP, Alberts DS, Einspahr JG, Sagerman PM, Warneke JA, Curiel-Lewandrowski C, Myrdal PB, Karlage KL, Nickoloff BJ, Brooks C, Saboda K, Yozwiak ML, Krutzsch MF, Hu C, Lluria-Prevatt M, et al. A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer. Cancer Prevention Research (Philadelphia, Pa.). 3: 160-9. PMID 20103724 DOI: 10.1158/1940-6207.Capr-09-0183  0.303
2010 Karlage KL, Mogalian E, Jensen A, Myrdal PB. Inhalation of an ethanol-based zileuton formulation provides a reduction of pulmonary adenomas in the A/J mouse model. Aaps Pharmscitech. 11: 168-73. PMID 20101484 DOI: 10.1208/S12249-009-9371-6  0.728
2009 Kuehl PJ, Stratton SP, Powell MB, Myrdal PB. Preformulation, formulation, and in vivo efficacy of topically applied apomine. International Journal of Pharmaceutics. 382: 104-10. PMID 19699284 DOI: 10.1016/J.Ijpharm.2009.08.016  0.679
2009 Hill SW, Varker AS, Karlage K, Myrdal PB. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. Journal of Managed Care Pharmacy : Jmcp. 15: 253-61. PMID 19326956 DOI: 10.18553/Jmcp.2009.15.3.253  0.316
2009 Sanghvi R, Mogalian E, Machatha SG, Narazaki R, Karlage KL, Jain P, Tabibi SE, Glaze E, Myrdal PB, Yalkowsky SH. Preformulation and pharmacokinetic studies on antalarmin: a novel stress inhibitor. Journal of Pharmaceutical Sciences. 98: 205-14. PMID 18428980 DOI: 10.1002/Jps.21421  0.744
2008 Mogalian E, Sepassi K, Myrdal PB. Accounting for the effects of moderately increased pressure on the energetics of melting and solubility in metered dose inhalers. Drug Development and Industrial Pharmacy. 34: 930-5. PMID 18800253 DOI: 10.1080/03639040802154871  0.721
2008 Hoye JA, Myrdal PB. Measurement and correlation of solute solubility in HFA-134a/ethanol systems. International Journal of Pharmaceutics. 362: 184-8. PMID 18647644 DOI: 10.1016/J.Ijpharm.2008.06.020  0.762
2008 Kuehl PJ, Brenner T, Jain PK, Karlage K, Sepassi K, Yang G, Mayersohn M, Yalkowsky SH, Myrdal PB. Formulation and in vivo evaluation of chlorpropham (CIPC) oral formulations. Journal of Pharmaceutical Sciences. 97: 5222-8. PMID 18383335 DOI: 10.1002/Jps.21384  0.689
2008 Hoye JA, Gupta A, Myrdal PB. Solubility of solid solutes in HFA-134a with a correlation to physico-chemical properties. Journal of Pharmaceutical Sciences. 97: 198-208. PMID 17828733 DOI: 10.1002/Jps.21080  0.765
2007 Mogalian E, Kuehl PJ, Myrdal PB. New analytical techniques to facilitate preformulation screening in propellant systems. International Journal of Pharmaceutics. 340: 223-9. PMID 17498897 DOI: 10.1016/J.Ijpharm.2007.03.026  0.776
2007 Myrdal PB, Karlage K, Kuehl PJ, Angersbach BS, Merrill BA, Wightman PD. Effects of novel 5-lipoxygenase inhibitors on the incidence of pulmonary adenomas in the A/J murine model when administered via nose-only inhalation. Carcinogenesis. 28: 957-61. PMID 17114645 DOI: 10.1093/Carcin/Bgl216  0.663
2006 Harris JA, Stein SW, Myrdal PB. Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers. Aaps Pharmscitech. 7: E138-E145. PMID 28290035 DOI: 10.1208/Pt070120  0.402
2006 Myrdal PB, Mogalian E, Mitchell J, Nagel M, Wright C, Kiser B, Prell M, Woessner M, Stein SW. Application of heated inlet extensions to the TSI 3306/3321 system: comparison with the Andersen cascade impactor and next generation impactor. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 19: 543-54. PMID 17196082 DOI: 10.1089/Jam.2006.19.543  0.731
2006 Myrdal PB, Angersbach BS, Karlage K, Kuehl PJ. Chiral separation of lipoxygenase metabolites utilizing high-performance liquid chromatography. Journal of Chromatography. A. 1132: 315-9. PMID 17005188 DOI: 10.1016/J.Chroma.2006.07.010  0.612
2006 Kuehl PJ, Hoye WL, Myrdal PB. Preformulation studies on imexon. Drug Development and Industrial Pharmacy. 32: 687-97. PMID 16885124 DOI: 10.1080/03639040600599830  0.734
2006 Kuehl PJ, Angersbach BS, Stratton SP, Myrdal PB. Development of an HPLC method for the analysis of Apomine in a topical cream formulation. Journal of Pharmaceutical and Biomedical Analysis. 40: 975-80. PMID 16181759 DOI: 10.1016/J.Jpba.2005.07.046  0.637
2006 Harris JA, Stein SW, Myrdal PB. Erratum: Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers (AAPS PharmaSciTech) Aaps Pharmscitech. 7. DOI: 10.1208/Pt070381  0.355
2006 Kuehl PJ, Carducci MD, Myrdal PB. 4-Imino-1,3-diazabicyclo[3.1.0]hexan-2-one Acta Crystallographica Section E Structure Reports Online. 62: o3688-o3690. DOI: 10.1107/S1600536806029412  0.62
2006 Stein SW, Myrdal PB. The Relative Influence of Atomization and Evaporation on Metered Dose Inhaler Drug Delivery Efficiency Aerosol Science and Technology. 40: 335-347. DOI: 10.1080/02786820600612268  0.373
2005 Karlage KL, Myrdal PB. Comparison of three pharmaceutical products obtained from Mexico and the United States: a case study. Drug Development and Industrial Pharmacy. 31: 993-1000. PMID 16316855 DOI: 10.1080/03639040500306245  0.319
2005 Mogalian E, Myrdal PB. Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers. Drug Development and Industrial Pharmacy. 31: 977-85. PMID 16316853 DOI: 10.1080/03639040500306211  0.761
2005 Hoye WL, Mogalian EM, Myrdal PB. Effects of extreme temperatures on drug delivery of albuterol sulfate hydrofluoroalkane inhalation aerosols. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 62: 2271-7. PMID 16239418 DOI: 10.2146/Ajhp050067  0.738
2005 Gupta A, Myrdal PB. A comparison of two methods to determine the solubility of compounds in aerosol propellants. International Journal of Pharmaceutics. 292: 201-9. PMID 15725567 DOI: 10.1016/J.Ijpharm.2005.01.001  0.338
2004 Myrdal PB, Stein SW, Mogalian E, Hoye W, Gupta A. Comparison of the TSI Model 3306 Impactor Inlet with the Andersen Cascade Impactor: solution metered dose inhalers. Drug Development and Industrial Pharmacy. 30: 859-68. PMID 15521331 DOI: 10.1081/Ddc-200034575  0.757
2004 Gupta A, Myrdal PB. Novel method for the determination of solubility in aerosol propellants. Journal of Pharmaceutical Sciences. 93: 2411-9. PMID 15349951 DOI: 10.1002/Jps.20154  0.37
2004 Stein SW, Myrdal PB. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. Journal of Pharmaceutical Sciences. 93: 2158-75. PMID 15236462 DOI: 10.1002/Jps.20116  0.336
2004 Gupta A, Myrdal PB. On-line high-performance liquid chromatography method for analyte quantitation from pressurized metered dose inhalers. Journal of Chromatography. A. 1033: 101-6. PMID 15072294 DOI: 10.1016/J.Chroma.2004.01.034  0.36
2004 Myrdal PB, Karlage KL, Stein SW, Brown BA, Haynes A. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers. Journal of Pharmaceutical Sciences. 93: 1054-61. PMID 14999741 DOI: 10.1002/Jps.20025  0.417
2004 Gupta A, Myrdal PB. Development of a perillyl alcohol topical cream formulation. International Journal of Pharmaceutics. 269: 373-83. PMID 14706249 DOI: 10.1016/J.Ijpharm.2003.09.026  0.364
2003 Gupta A, Stein SW, Myrdal PB. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 16: 167-74. PMID 12823910 DOI: 10.1089/089426803321919924  0.408
2003 Stein SW, Myrdal PB, Gabrio BJ, Obereit D, Beck TJ. Evaluation of a new Aerodynamic Particle Sizer Spectrometer for size distribution measurements of solution metered dose inhalers. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 16: 107-19. PMID 12823905 DOI: 10.1089/089426803321919870  0.327
2003 Kuehl PJ, Carducci MD, Myrdal PB. An ethanol solvate of Beclomethasone dipropionate Acta Crystallographica Section E Structure Reports Online. 59: o1888-o1890. DOI: 10.1107/S1600536803024425  0.643
1995 Myrdal PB, Simamora P, Surakitbanharn Y, Yalkowsky SH. Studies in phlebitis. VII: In vitro and in vivo evaluation of pH‐solubilized levemopamil Journal of Pharmaceutical Sciences. 84: 849-852. PMID 7562436 DOI: 10.1002/Jps.2600840713  0.39
Show low-probability matches.